an update on mrd assessment and novel techniques used in the treatment of hematological malignancies
Published 2 years ago • 94 plays • Length 2:35Download video MP4
Download video MP3
Similar videos
-
2:25
master final analysis: quadruplet induction therapy, asct & mrd-adapted treatment cessation in ndmm
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
1:38
mrd as a marker in follicular lymphoma: importance and limitations
-
1:19
the prognostic value of mrd in cll
-
4:40
management of r/r myeloma and mrd assessment
-
1:23
the value of mrd as a marker for disease eradication in aml
-
3:22
the impact of mrd as a biomarker
-
1:45
role for mrd assessment in al amyloidosis?
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
21:38
drawing the line: the rationale behind blood tube collection order
-
1:00:00
activate 100% brain potential - genius brain frequency - beta waves (brainwaves)
-
1:32
methods to evaluate mrd in aml
-
1:49
bringing precision medicine and mrd into clinical strategies
-
1:30
the clinical application of mrd testing in aml
-
2:03
prognostic significance of molecular mrd in npm1-mutated aml treated with venetoclax-based therapy
-
2:22
improve study: mrd assessment as an endpoint to define treatment length and intensity in cll
-
1:59
the role of mrd as a prognostic & predictive biomarker in cll
-
1:40
updates on the use of molecular monitoring to detect mrd in aml
-
3:27
the role of mrd in aml regulatory decision making
-
5:46
mrd: standardization and application
-
2:43
interim analysis of the elm-2 study: odronextamab in patients with r/r follicular lymphoma
-
1:06
assessing metabolic tumor volume as a prognostic marker before car-t therapy for dlbcl